Friday, May 16, 2014

No down payment medical, dental and healthcare provider practice financing here! + More News: Promising cancer drug data helps AstraZeneca in Pfizer fight + MORE 05/16/2014


Medical Professional financing for your medical practice!  Learn how to get funding with medical practice financing. More Info Here!



Call: 904-551-6090




Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.


Read The Interesting Snippets Below For Exciting Health-Care News!





(Reuters) – New data showing an experimental AstraZeneca lung cancer drug shrank tumors in more than half of patients gave the British group fresh ammunition to argue that Pfizer’s takeover offer undervalues it substantially.

Continue Reading On http://www.reuters.com/healthNews »




* Synergy health plc – acquisition of bioster spa and associated companies

Continue Reading On http://www.reuters.com »




SAN FRANCISCO, May 15 (Reuters) – California in November will vote on whether to raise a four-decade-old cap on medical malpractice awards to $1.1 million, from $250,000, officials said on Thursday, likely ensuring a bitter and costly fight between lawyers backing the measure and doctors who oppose it.

Continue Reading On http://www.reuters.com »




Muscle pain not well defined in most statin studies


– http://www.reuters.com/healthNews


NEW YORK (Reuters Health) – Studies evaluating cholesterol-lowering drugs might find more muscle problems if they did a better job of defining and asking about muscle pain, suggests a new review.

Continue Reading On http://www.reuters.com/healthNews »




May 16 (Reuters) – Danish drugmaker Novo Nordisk said results from the largest trial of its experimental obesity treatment liraglutide showed an 8 percent weight loss compared to 2.6 percent with placebo after a year of treatment.

Continue Reading On http://www.reuters.com »




SHANGHAI, May 16 (Reuters) – Corruption charges against British drugmaker GlaxoSmithKline Plc in China are a “warning” to other foreign firms operating in the country that unethical behaviour will be punished, according to a commentary from the official Xinhua news agency on Friday.

Continue Reading On http://www.reuters.com »




No down payment medical, dental and healthcare provider practice financing here! + More News: Promising cancer drug data helps AstraZeneca in Pfizer fight + MORE 05/16/2014